eudragit rs has been researched along with Disease Models, Animal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katara, R; Majumdar, DK; Sachdeva, S | 1 |
| Adedokun, MO; Attama, AA; Kenechukwu, FC; Momoh, MA; Odo, CE | 1 |
| Cao, J; Choi, M; Ikram, M; Jung, Y; Kim, MS; Lee, J; Lee, Y; Moon, HR; Naeem, M; Yoo, JW; Yoon, S | 1 |
| Bhagav, P; Chandran, S; Upadhyay, H | 1 |
| Attizzani, G; Balvedi, JA; Centeno, PR; Kosachenco, BG; Matte, BS; Nascimento, L; Raudales, JC; Yamamoto, GI; Zago, AC; Zago, AJ | 1 |
5 other study(ies) available for eudragit rs and Disease Models, Animal
| Article | Year |
|---|---|
Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Chemistry, Pharmaceutical; Crystallization; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Eye Diseases; Inflammation; Nanoparticles; Neutrophils; Particle Size; Rabbits | 2019 |
Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres.
Topics: Acrylic Resins; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Drug Carriers; Female; Hydrogen-Ion Concentration; Inflammation; Male; Microspheres; Particle Size; Rats, Wistar; Solubility; Technology, Pharmaceutical | 2014 |
Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Topics: Acrylic Resins; Animals; Anti-Inflammatory Agents; Budesonide; Colitis; Colon; Delayed-Action Preparations; Dextran Sulfate; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred ICR; Nanoparticles; Polymethacrylic Acids; Time Factors | 2015 |
Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.
Topics: Acrylic Resins; Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Glaucoma; Hydrogen-Ion Concentration; Intraocular Pressure; Kinetics; Nanoparticles; Nanotechnology; Quinoxalines; Rabbits; Solubility; Technology, Pharmaceutical | 2011 |
Local delivery of sirolimus nanoparticles for the treatment of in-stent restenosis.
Topics: Acrylic Resins; Animals; Cardiac Catheters; Cardiovascular Agents; Chemistry, Pharmaceutical; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Equipment Design; Infusions, Parenteral; Lactic Acid; Nanoparticles; Neointima; Percutaneous Coronary Intervention; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Porosity; Sirolimus; Swine; Time Factors; Ultrasonography, Interventional | 2013 |